LakeShore Biopharma
Yahoo Finance • 3 days ago
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting
BEIJING, Sept. 22, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generat... Full story
Yahoo Finance • last month
LakeShore Biopharma receives $0.86/share buyout proposal from Oceanpine Capital
* Oceanpine Capital submitted a preliminary non-binding proposal to acquire all outstanding shares of LakeShore Biopharma (NASDAQ:LSB [https://seekingalpha.com/symbol/LSB]) not already owned. * The proposed all-cash offer is $0.86/shar... Full story
Yahoo Finance • 3 months ago
LakeShore Biopharma secures $15 million in private placement
BEIJING - LakeShore Biopharma Co., Ltd (NASDAQ:LSB), a biopharmaceutical company focused on vaccines and therapeutic biologics with a current market capitalization of $18.71 million, announced Tuesday it has entered into a share and warran... Full story
